Skip to main content
. 2024 Aug 27;12:74. doi: 10.1186/s40635-024-00655-2

Table 2.

Characteristics after ARDS induction and before VV-ECMO start in the three groups

Variables N control N hypothermia N β-blocker p-value
General parameters
 Central temperature(℃) 6 38.7 (38.6–38.8) 9 38.3 (38.0–38.5) 7 38.4 (38.2–38.5) 0.005
 Hemoglobin level (g.dl−1) 6 10.4 (9.7–10.7) 9 9.0 (8.6–10.0) 7 9.5 (9.0–10.2) 0.15
Hemodynamic parameters
 Mean arterial pressure (mmHg) 6 84 (78–85) 9 69 (66–72) 7 70 (65–70) 0.012
 Heart rate (bpm) 6 138 (124–142) 9 153 (136–174) 7 138 (133–140) 0.22
 Cardiac output (l.min−1) 6 7.9 (7.5–8.7) 9 8.2 (7.5–9.4) 7 7.6 (7.3–8.0) 0.28
 Lactate (mmol.l−1) 6 1.4 (0.9–1.5) 9 1.0 (0.8–1.7) 7 1.8 (1.0–2.1) 0.65
 Norepinephrine dose (γg.kg−1.min−1) 6 0.5 (0.4–0.6) 9 1.1 (0.8–4.5) 7 0.4 (0.3–1.0) 0.019
 *Fluid expansion (ml) 6 500 (500–1000) 9 900 (750–1000) 7 1000 (1000–1500) 0.041
Respiratory parameters
 Sao2 (%) 6 74 (67–80) 9 79 (78–85) 7 77 (72–81) 0.14
 Pao2/fio2 6 48 (44–55) 9 57 (55–60) 7 54 (45–60) 0.14
 Fio2 (%) 6 100 (100–100) 9 100 (100–100) 7 100 (100–100) -
 Static compliance (ml.cmh2O−1) 6 24 (23–25) 9 21 (17–24) 7 20 (19–20) 0.048

Data are expressed as median, 25 e and 75e quantile. *Sum of fluids administered during the ARDS procedure